日立澄清未有計劃將英國核電項目出售予中國
日立(Hitachi)表示,未有計劃將英國核電項目出售予中國。較早時英國《星期日泰晤士報》報道,美國總統特朗普已警告日立不得將在威爾士的核電站出售予中國。
報道稱,中廣核(01816.HK)希望能收購核電站,作為建造核反應堆艦隊計劃的一部分。
日立去年凍結這個227億英鎊的項目,並為英國核業務減值3,000億日圓,因該項目未能找到私人投資者。當時有消息人士稱,日立曾要求英國政府增加對該項目的財政支持,但因英國忙於脫歐而未能成事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.